Fulgent Genetics, Inc.
$493.16M- Market cap
- $542.88M
- Debt
- +$476.00K
- Cash
- −$50.19M
Capital structure 100% equity / 0% debt · EV / Revenue 1.53x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
FLGT · current priceP/S 1.68x
$19.73Latest market snapshot
Implied fair value · at CLOV's multiple
$13.5831.2% below market
11.73 FLGT revenue / share×1.16x CLOV P/S=$13.58
Market $19.73Implied $13.58
CLOV · current priceP/S 1.16x
$4.26Latest market snapshot
Implied fair value · at FLGT's multiple
$6.3248.6% above market
3.76 CLOV revenue / share×1.68x FLGT P/S=$6.32
Market $4.26Implied $6.32